Trimethoprim/sulfamethoxazole (TMP/SMX) resistance remains a serious threat in the treatment of Stenotrophomonas maltophilia infections. We analyzed an international collection of 55 S. maltophilia TMP/SMX-sensitive (S) (n=30) and -resistant (R) (n=25) strains for integrons; sul1, sul2 and dhfr genes; and insertion element common region (ISCR) elements. sul1, as part of a class 1 integron, was detected in 17 of 25 TMP/SMX-R. Nine TMP/SMX-R strains carried sul2; 7 were on large plasmids. Five TMP/SMX-R isolates were positive for ISCR2, and 4 were linked to sul2; 2 others possessed ISCR3. Two ISCR2s were adjacent to floR. Six TMP/SMX-S isolates harbored novel ISCR elements, ISCR9 and ISCR10. Linkage of ISCR3, ISCR9, and ISCR10 to sul2 and dhf...
Stenotrophomonas maltophilia has emerged as an important nosocomial pathogen. Treatment of S. maltop...
Objectives: Stenotrophomonas maltophilia is a recently identified nosocomial pathogen in Malaysia. D...
Trimethoprim-sulfamethoxazole (co-trimoxazole) is one of the antimicrobials of choice for the treatm...
Trimethoprim/sulfamethoxazole (TMP/SMX) resistance remains a serious threat in the treatment of Sten...
Trimethoprim/sulfamethoxazole (TMP/SMX) resistance remains a serious threat in the treatment of Sten...
Trimethoprim/sulfamethoxazole (TMP/SMX) resistance remains a serious threat in the treatment of Sten...
Background: Stenotrophomonas maltophilia is a gram-negative bacillus and a nosocomial pathogen in im...
Emerging resistance to trimethoprim/sulfamethoxazole (SXT) poses a serious threat to the treatment o...
Emerging resistance to trimethoprim/sulfamethoxazole (SXT) poses a serious threat to the treatment o...
Stenotrophomonas maltophilia is an important multidrug resistant nosocomial pathogen. Trimethoprim/s...
Treatment of Stenotrophomonas maltophilia infections comprises of sulfamethoxazole/tripethoprim (SXT...
Stenotrophomonas maltophilia has received considerable atten-tion owing to its high infection rate a...
[[abstract]]Two hundred clinical isolates of Stenotrophomonas maltophilia were examined for the pres...
SummaryObjectivesStenotrophomonas maltophilia is a recently identified nosocomial pathogen in Malays...
Resistance to antibiotics is becoming an important global public health problem. Infectious diseases...
Stenotrophomonas maltophilia has emerged as an important nosocomial pathogen. Treatment of S. maltop...
Objectives: Stenotrophomonas maltophilia is a recently identified nosocomial pathogen in Malaysia. D...
Trimethoprim-sulfamethoxazole (co-trimoxazole) is one of the antimicrobials of choice for the treatm...
Trimethoprim/sulfamethoxazole (TMP/SMX) resistance remains a serious threat in the treatment of Sten...
Trimethoprim/sulfamethoxazole (TMP/SMX) resistance remains a serious threat in the treatment of Sten...
Trimethoprim/sulfamethoxazole (TMP/SMX) resistance remains a serious threat in the treatment of Sten...
Background: Stenotrophomonas maltophilia is a gram-negative bacillus and a nosocomial pathogen in im...
Emerging resistance to trimethoprim/sulfamethoxazole (SXT) poses a serious threat to the treatment o...
Emerging resistance to trimethoprim/sulfamethoxazole (SXT) poses a serious threat to the treatment o...
Stenotrophomonas maltophilia is an important multidrug resistant nosocomial pathogen. Trimethoprim/s...
Treatment of Stenotrophomonas maltophilia infections comprises of sulfamethoxazole/tripethoprim (SXT...
Stenotrophomonas maltophilia has received considerable atten-tion owing to its high infection rate a...
[[abstract]]Two hundred clinical isolates of Stenotrophomonas maltophilia were examined for the pres...
SummaryObjectivesStenotrophomonas maltophilia is a recently identified nosocomial pathogen in Malays...
Resistance to antibiotics is becoming an important global public health problem. Infectious diseases...
Stenotrophomonas maltophilia has emerged as an important nosocomial pathogen. Treatment of S. maltop...
Objectives: Stenotrophomonas maltophilia is a recently identified nosocomial pathogen in Malaysia. D...
Trimethoprim-sulfamethoxazole (co-trimoxazole) is one of the antimicrobials of choice for the treatm...